SCHEMBL4630647

SCHEMBL4630647

CCCC(=O)N1[CH]CNCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNB3 Q05901 1/20 0.36
CHRNA6 Q15825 1/20 0.36
FAAH O00519 1/20 0.35
NAAA Q02083 1/20 0.35
GNAI3 P08754 5/20 0.34
GNAO1 P09471 5/20 0.34
GNAI1 P63096 5/20 0.34
GAA P10253 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MAPT P10636 2/20 0.31
SIGMAR1 Q99720 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KDM1A O60341 1/20 0.30
KDM1B Q8NB78 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630955 0.85 CHRNB2 (0.35) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL3889279 0.75 TSHR (0.37) FAAHGAAL3MBTL1MAPTALDH1A1
SCHEMBL603100 0.75
SCHEMBL7786235 0.75 KMT2A (0.38) CHRNB2CHRNA3CHRNA4GNAI3GNAO1
Hydrochloric Acid SCHEMBL27699750 0.74 TSHR (0.36) FAAHGAAL3MBTL1MAPTALDH1A1
SCHEMBL2645151 0.73 L3MBTL1 (0.42) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL6961571 0.72
SCHEMBL2646658 0.72 L3MBTL1 (0.46) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL10514 0.71 GNAI3 (0.50) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL3891537 0.70 CHRNB2 (0.35) CHRNB2CHRNA3CHRNA4L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
EP-0823420-B1 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO (JP) 2001-10-24 EP disclosed
US-5866609-A PROPHYLACTIC AND THERAPEUTIC AGENTS FOR ARTERIOSCLEROSIS. SS PHARMACEUTICAL CO., LTD. (JP) 1999-02-02 US disclosed
EP-0823420-A2 Substituted vinylurea derivatives and their use as ACAT inhibitors SS PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed